Literature DB >> 29630047

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology.

Kenji Amemiya1, Yosuke Hirotsu2, Toshio Oyama3, Masao Omata4.   

Abstract

It is critical to determine the mutational status in cancer before administration and treatment of specific molecular targeted drugs for cancer patients. In the clinical setting, formalin-fixed paraffin-embedded (FFPE) tissues are widely used for genetic testing. However, FFPE DNA is generally damaged and fragmented during the fixation process with formalin. Therefore, FFPE DNA is sometimes not adequate for genetic testing because of low quality and quantity of DNA. Here we present a method of touch imprint cytology (TIC) to obtain genomic DNA from cancer cells, which can be observed under a microscope. Cell morphology and cancer cell numbers can be evaluated using TIC specimens. Furthermore, the extraction of genomic DNA from TIC samples can be completed within two days. The total amount and quality of TIC DNA obtained using this method was higher than that of FFPE DNA. This rapid and simple method allows researchers to obtain high-quality DNA for genetic testing (e.g., next generation sequencing analysis, digital PCR, and quantitative real time PCR) and to shorten the turnaround time for reporting results.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630047      PMCID: PMC5933238          DOI: 10.3791/56943

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  24 in total

Review 1.  Effect of fixatives and tissue processing on the content and integrity of nucleic acids.

Authors:  Mythily Srinivasan; Daniel Sedmak; Scott Jewell
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Utility of touch imprint cytology in the preoperative diagnosis of malignancy in low resource setting.

Authors:  Amit Kumar Adhya; Ranjan Mohanty
Journal:  Diagn Cytopathol       Date:  2017-03-07       Impact factor: 1.582

3.  Usefulness of intraoperative touch smear cytology in breast-conserving surgery.

Authors:  Kazuhiro Sumiyoshi; Takehiro Nohara; Mitsuhiko Iwamoto; Satoru Tanaka; Kosei Kimura; Yuko Takahashi; Yoshitaka Kurisu; Motomu Tsuji; Nobuhiko Tanigawa
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

Review 4.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

5.  Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient.

Authors:  Yosuke Hirotsu; Hiroshi Nakagomi; Kenji Amemiya; Toshio Oyama; Masayuki Inoue; Hitoshi Mochizuki; Masao Omata
Journal:  Med Oncol       Date:  2016-11-29       Impact factor: 3.064

6.  KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Authors:  Astrid Lièvre; Jean-Baptiste Bachet; Delphine Le Corre; Valérie Boige; Bruno Landi; Jean-François Emile; Jean-François Côté; Gorana Tomasic; Christophe Penna; Michel Ducreux; Philippe Rougier; Frédérique Penault-Llorca; Pierre Laurent-Puig
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

7.  The Path to Cancer --Three Strikes and You're Out.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  N Engl J Med       Date:  2015-11-12       Impact factor: 91.245

8.  Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer.

Authors:  Yosuke Hirotsu; Hiroshi Nakagomi; Ikuko Sakamoto; Kenji Amemiya; Toshio Oyama; Hitoshi Mochizuki; Masao Omata
Journal:  Mol Genet Genomic Med       Date:  2015-05-12       Impact factor: 2.183

9.  Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.

Authors:  Stephen Q Wong; Jason Li; Renato Salemi; Karen E Sheppard; Hongdo Do; Richard W Tothill; Grant A McArthur; Alexander Dobrovic
Journal:  Sci Rep       Date:  2013-12-13       Impact factor: 4.379

10.  Touch imprint cytology with massively parallel sequencing (TIC-seq): a simple and rapid method to snapshot genetic alterations in tumors.

Authors:  Kenji Amemiya; Yosuke Hirotsu; Taichiro Goto; Hiroshi Nakagomi; Hitoshi Mochizuki; Toshio Oyama; Masao Omata
Journal:  Cancer Med       Date:  2016-10-24       Impact factor: 4.452

View more
  1 in total

1.  Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.

Authors:  Yuki Nagakubo; Yosuke Hirotsu; Kenji Amemiya; Toshio Oyama; Hitoshi Mochizuki; Masao Omata
Journal:  BMC Med Genomics       Date:  2019-11-11       Impact factor: 3.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.